Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality

摘要

The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as β blockers and thrombolytic agents. The preferred inhibitor is captopril.